[Sentinel lymph node biopsy in male breast cancer - a case report].

Gan To Kagaku Ryoho

Dept. of Gastroenterological Surgery, Breast and Thyroid Surgery, Hirosaki University Graduate School of Medicine.

Published: November 2014

We report a case of breast cancer in a man who underwent sentinel lymph node biopsy (SLNB). The patient, a 66-year-old man, observed a tumor under his left areola. The elastic hard tumor had a clear border. Ultrasonography revealed a hypoechoic tumor, approximately 18 mm in diameter, in the left subareolar and outer upper region. On fine needle aspiration cytology (FNAC), the tumor was diagnosed as a ductal carcinoma. The patient underwent a mastectomy (Bt) and an axillaryly mph node dissection(Ax)after the SLNB. The SLNB was performed with the blue dye alone. Based on histopathological observations, estrogen receptor (ER)- and progesterone receptor (PgR)-positive invasive micropapillary carcinoma was diagnosed. The human epidermal growth factor receptor 2(HER2) score was 1+, and Ki-67 labeling index was 30%. Lymph node metastasis was not seen in SLNB (0/1) and Ax (0/13). Postoperatively, the patient received oral tamoxifen therapy. There was no evidence of recurrence during the 9-month follow-up. In this case, computed tomographic (CT) lymphography (CTLG) and SLNB were performed successfully, without incident. We recommend SLNB in cases of male breast cancer with clinically negative nodes.

Download full-text PDF

Source

Publication Analysis

Top Keywords

lymph node
12
breast cancer
12
node biopsy
8
male breast
8
slnb performed
8
slnb
6
[sentinel lymph
4
node
4
biopsy male
4
cancer case
4

Similar Publications

Importance: Endocrine treatments, such as Tamoxifen (TAM) and/or Aromatase inhibitors (AI), are the adjuvant therapy of choice for hormone-receptor positive breast cancer. These agents are associated with menopausal symptoms, adversely affecting drug compliance. Topical estrogen (TE) has been proposed for symptom management, given its' local application and presumed reduced bioavailability, however its oncological safety remains uncertain.

View Article and Find Full Text PDF

Rare dual MYH9-ROS1 fusion variants in a patient with lung adenocarcinoma: A case report.

Medicine (Baltimore)

January 2025

Department of Respiratory and Critical Care Medicine, Zhongshan City People's Hospital, Zhongshan, Guangdong Province, China.

Rationale: ROS proto-oncogene 1 (ROS1) fusion is a rare but important driver mutation in non-small cell lung cancer, which usually shows significant sensitivity to small molecule tyrosine kinase inhibitors. With the widespread application of next-generation sequencing (NGS), more fusions and co-mutations of ROS1 have been discovered. Non-muscle myosin heavy chain 9 (MYH9) is a rare fusion partner of ROS1 gene as reported.

View Article and Find Full Text PDF

Solitary Axillary Lymph Node Metastasis From Ovarian Cancer on 18F-FDG PET/CT.

Clin Nucl Med

January 2025

From the Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

Solitary axillary lymph node metastasis from ovarian cancer is rare. A 74-year-old woman who had undergone hysterectomy and bilateral salpingo-oophorectomy for ovarian cancer 2 years ago presented to our hospital with enlarged axillary lymph node. 18F-FDG PET/CT revealed left axillary lymphadenopathy with an SUVmax of 8.

View Article and Find Full Text PDF

Evolution of SARS-CoV-2 in white-tailed deer in Pennsylvania 2021-2024.

PLoS Pathog

January 2025

Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

SARS-CoV-2 continues to transmit and evolve in humans and animals. White-tailed deer (Odocoileus virginianus) have been previously identified as a zoonotic reservoir for SARS-CoV-2 with high rates of infection and probable spillback into humans. Here we report sampling 1,127 white-tailed deer (WTD) in Pennsylvania, and a genomic analysis of viral dynamics spanning 1,017 days between April 2021 and January 2024.

View Article and Find Full Text PDF

Background: Neuroendocrine tumors of the thymus (NETT) are rare and malignant tumors that arise in the anterior mediastinum. These tumors can exhibit aggressive behavior and may involve surrounding critical structures, such as the superior vena cava. This case contributes to the literature by presenting a recurrent thymic carcinoma with invasion of major blood vessels, including the superior vena cava, and the complexities involved in its surgical management.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!